ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 176 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $751,000 | +41.7% | 69,582 | -9.1% | 0.12% | +74.6% |
| Q3 2015 | $530,000 | -24.0% | 76,540 | -2.7% | 0.07% | -25.3% |
| Q2 2015 | $697,000 | -18.1% | 78,704 | -8.9% | 0.10% | -7.8% |
| Q1 2015 | $851,000 | -33.9% | 86,352 | -17.9% | 0.10% | -36.0% |
| Q4 2014 | $1,288,000 | +157.1% | 105,165 | +109.7% | 0.16% | +106.4% |
| Q3 2014 | $501,000 | – | 50,141 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,700,000 | $82,075,000 | 8.82% |
| RTW INVESTMENTS, LP | 1,622,633 | $19,877,000 | 7.35% |
| ProQuest Associates IV LLC | 1,122,957 | $13,757,000 | 6.97% |
| RA Capital Management | 2,500,000 | $30,625,000 | 3.29% |
| DOHENY ASSET MANAGEMENT /CA | 517,450 | $6,339,000 | 3.03% |
| DAFNA Capital Management LLC | 197,500 | $2,419,000 | 1.91% |
| Rhenman & Partners Asset Management AB | 368,000 | $4,508,000 | 1.31% |
| SECTORAL ASSET MANAGEMENT INC | 2,373,810 | $29,079,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,920,300 | $35,774,000 | 1.28% |
| Bain Capital Public Equity Management, LLC | 2,928,750 | $35,877,000 | 0.90% |